Navegar

Colección

Datos Estadísticas

Lista de

Mammary Neoplasms, Experimental
43
"Microenvironmental influence on microtumour infiltration patterns: 3D-mathematical modelling supported by: In vitro studies" (2018) Luján, E.;Soto, D.;Rosito, M.S. (...)Suárez, C. Integrative Biology (United Kingdom). 10(5):325-334
"Predictive outcomes for HER2-enriched cancer using growth and metastasis signatures driven by SPARC" (2017) Guttlein, L.N.;Benedetti, L.G.;Fresno, C. (...)Podhajcer, O.L. Molecular Cancer Research. 15(3):304-316
"The role of estrogen receptor alpha in breast cancer cell proliferation mediated by progestins " (2012) Lanari, C.;Giulianelli, S.;Vaqué, J.P. (...)Gutkind, J.S. Medicina (Argentina). 72(4):315-320
"Reversal of antiprogestin resistance and progesterone receptor isoform ratio in acquired resistant mammary carcinomas" (2009) Wargon, V.;Helguero, L.A.;Bolado, J. (...)Lanari, C. Breast Cancer Research and Treatment. 116(3):449-460
"MMTV-induced pregnancy-dependent mammary tumors: Early history and new perspectives" (2008) Kordon, E.C. Journal of Mammary Gland Biology and Neoplasia. 13(3):289-297
"Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling" (2007) Quaglino, A.;Schere-Levy, C.;Romorini, L. (...)Kordon, E.C. Breast Cancer Research. 9(5)
"Selection of early-occurring mutations dictates hormone-independent progression in mouse mammary tumor lines" (2006) Gattelli, A.;Zimberlin, M.N.;Meiss, R.P. (...)Kordon, E.C. Journal of Virology. 80(22):11409-11415
"Fibronectin is distinctly downregulated in murine mammary adenocarcinoma cells with high metastatic potential" (2006) Urtreger, A.J.;Werbajh, S.E.;Verrecchia, F. (...)Bal De Kier Joffé, E.D. Oncology Reports. 16(6):1403-1410
"Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation" (2006) Salatino, M.;Beguelin, W.;Peters, M.G. (...)Elizalde, P.V. Oncogene. 25(59):7723-7739
"Cytogenetic findings, Trp53 mutations, and hormone responsiveness in a medroxyprogesterone acetate induced murine breast cancer model" (2005) Fabris, V.T.;Benavides, F.;Conti, C. (...)Lanari, C. Cancer Genetics and Cytogenetics. 161(2):130-139
"Type I insulin-like growth factor receptor antisense strategies in experimental breast cancer " (2004) Salatino, M.;Schillaci, R.;Proietti, C.J. (...)Elizalde, P.V. Medicina. 64(2):129-134
"δ-aminolevulinic acid transport in murine mammary adenocarcinoma cells is mediated by beta transporters" (2002) Bermúdez Moretti, M.;Correa García, S.;Perotti, C. (...)Casas, A. British Journal of Cancer. 87(4):471-474
"Reversal of estrogen-resistance in murine mammary adenocarcinomas" (1999) Montecchia, M.F.; Molinolo, A.; Lanari, C. Breast Cancer Research and Treatment. 54(2):93-99
"Tissue distribution and kinetics of endogenous porphyrins synthesized after topical application of ALA in different vehicles" (1999) Casas, A.; Fukuda, H.; Del C Batlle, A.M. British Journal of Cancer. 81(1):13-18
"Promoter effect of medroxyprogesterone acetate (MPA) in N-methyl-N-nitrosourea (MNU) induced mammary tumors in BALB/c mice" (1998) Pazos, P.;Lanari, C.;Elizalde, P. (...)Molinolo, A.A. Carcinogenesis. 19(3):529-531
"Involvement of insulin-like growth factors-I and-II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas" (1998) Elizalde, P.V.;Lanari, C.;Molinolo, A.A. (...)Charreau, E.H. Journal of Steroid Biochemistry and Molecular Biology. 67(4):305-317
"Potentiation of the 5-aminolevulinic acid-based photodynamic therapy with cyclophosphamide" (1997) Casas, A.; Fukuda, H.; Batlle, A.M.D.C. Cancer Biochemistry Biophysics. 16(1):183-196
"Induccion de adenocarcinomas mamarios por progestagenos en ratones BALB/c: Progresion del tumor hormono-dependiente al autonomo" (1997) Lanari, C.;Montecchia, M.F.;Pazos, P. (...)Mounolo, A.A. Medicina. 57(SUPPL 2):55-69
"Enhancement of aminolevulinic acid based photodynamic therapy by adriamycin" (1997) Casas, A.; Fukuda, H.; Riley, P.; Del C. Batlle, A.M. Cancer Letters. 121(1):105-113
"Detection of endothelial cells by MEC 13.3 monoclonal antibody in mice mammary tumors" (1997) Vanzulli, S.;Gazzaniga, S.;Braidot, M.F. (...)Wainstok De Calmanovici, R. Biocell. 21(1):39-46
"Prazosin and stress effect on tumoral growth of 7,12-dimethylbenz[A]anthracene-induced rat mammary tumors" (1996) Wendel, V.;Maris Vazquez, S.;Durante, P.C. (...)Luthy, I.A. Acta Physiologica Pharmacologica et Therapeutica Latinoamericana. 46(4):277-285
"Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability" (1996) Guerra, F.K.;Eijan, A.M.;Puricelli, L. (...)Elizalde, P.V. International Journal of Cancer. 65(6):812-820
"Correlation of TGF-(si expression with medroxiprogesterone acetate responsiveness in mouse mammary adenocarcinomas" (1995) Elizalde, P.V.;Guerra, F.K.;Gravano, M. (...)Lupu, R. Cancer Investigation. 13(2):173-180
"Heparin receptors in two murine mammary adenocarcinomas with different metastatic ability: relationship with growth inhibition" (1995) Bertolesix, G.E.; de Cidre, L.L.; de Lustig, E.S.; Eiján, A.M. Cancer Letters. 90(2):123-131
"Growth inhibition in vitro of murine mammary adenocarcinoma cells by heparin and chemically modified heparins" (1994) Bertolesi, G.E.; De Cidre, L.L.; Eiján, A.M. Tumor Biology. 15(5):275-283
"Uroporhyrinogen decarboxylase from mouse mammary carcinoma and liver of normal and tumor-bearing mouse" (1992) Navone, N.M.; Afonso, S.G.; Polo, C.F.; del C. Battle, A.M. Comparative Biochemistry and Physiology -- Part B: Biochemistry and. 102(1):87-92
"Rhodanese and ALA-S in mammary tumor and liver from normal and tumor-bearing mice" (1992) Navone, N.M.; Vázquez, E.S.; Polo, C.F.; del C. Batlle, A.M. Comparative Biochemistry and Physiology -- Part B: Biochemistry and. 102(1):83-85
"Description of a new human breast cancer cell line, IIB-BR-G, established from a primary undifferentiated tumor" (1991) Bover, L.;Barrio, M.;Slavutsky, I. (...)Mordoh, J. Breast Cancer Research and Treatment. 19(1):47-56
"Mouse mammary carcinoma porphobilinogenase and hydroxymethylbilane synthetase" (1991) Navone, N.M.; Polo, C.F.; Frisardi, A.L.; M. del C. Batlle, A. Comparative Biochemistry and Physiology -- Part B: Biochemistry and. 98(1):67-71
"Adriamycin effects on hydroperoxide metabolism and growth of human breast tumor cells" (1990) Bustamante, J.; Galleano, M.; Medrano, E.E.; Boveris, A. Breast Cancer Research and Treatment. 17(2):145-153
"Synergistic effect of mammary tumors on hexachlorobenzene-induced porphyria in rats" (1990) Wainstok de Calmanovici, R.;Cochón, A.C.;Aldonatti, C. (...)San Martín de Viala, L.C. Cancer Letters. 55(1):67-73
"Mouse mammary carcinoma δ-aminolevulinate dehydratase" (1990) Navone, N.M.; Polo, C.F.; Frisardi, A.L.; Batlle, A.M.D.C. Comparative Biochemistry and Physiology -- Part B: Biochemistry and. 96(4):729-731
"Studies to determine the possible antitumoral properties of Cobra venom and of Crotoxin Complex A and B" (1988) Baldi, A.;Mordoh, J.;Medrano, E.E. (...)Rumi, L. Medicina. 48(4):337-344
"Correlation between urokinase-type plasminogen activator production and the metastasizing ability of two murine mammary adenocarcinomas" (1988) Pereyra-Alfonso, S.; Haedo, A.; de Kier Joffe, E.B. International Journal of Cancer. 42(1):59-63